mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients

BACKGROUND: Aberrant activation of the mammalian Target of Rapamycin (mTOR) pathway has been linked to obesity and endocrine therapy resistance, factors that may contribute to Black-White disparities in breast cancer outcomes. We evaluated associations of race and clinicopathological characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilozumba, Mmadili N., Yao, Song, Llanos, Adana A. M., Omilian, Angela R., Zhang, Weizhou, Datta, Susmita, Hong, Chi-Chen, Davis, Warren, Khoury, Thaer, Bandera, Elisa V., Higgins, Michael, Ambrosone, Christine B., Cheng, Ting-Yuan David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130392/
https://www.ncbi.nlm.nih.gov/pubmed/35608730
http://dx.doi.org/10.1007/s12672-022-00497-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130392/
https://www.ncbi.nlm.nih.gov/pubmed/35608730
http://dx.doi.org/10.1007/s12672-022-00497-y

Ejemplares similares